# Fanli Biotechnology (Ningbo) Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fanli-biotechnology-ningbo-co

- Industry: Biotechnology
- Headquarters: Ningbo, China
- Latest round: Series A (Jan 18, 2026)
- Investors on record: 3

## About

Based in Ningbo, China and founded in 2023, Fanli Biotechnology (Ningbo) Co., Ltd. is a biotechnology research and development company. 
In January 2026, Fanli Biotechnology (Ningbo) Co., Ltd. raised a Series A+ funding from Xiamen C&D Emerging Industry Equity Investment and Hongfeng Venture.

The company primarily engages in medical research and experimental development to meet the needs of clinical trials and related activities.

The company's revenue is generated by providing medical research and experimental development.

## Funding rounds

- Series A, Jan 18, 2026 — Xiamen C&D Emerging Industry Equity Investment, Hongfeng Venture
- Angel, Feb 13, 2025 — Kangjun Capital

## Investors

- Kangjun Capital (https://capitalatlas.ai/funds/kangjun-capital) — Angel
- Xiamen C&D Emerging Industry Equity Investment (https://capitalatlas.ai/funds/xiamen-c-d-emerging-industry-equity-investment) — Series A
- Hongfeng Venture (https://capitalatlas.ai/funds/hongfeng-venture) — Series A